-
Something wrong with this record ?
Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND)
L. Nanetti, M. Kearney, S. Boesch, L. Stovickova, JD. Ortigoza-Escobar, A. Macaya, D. Gomez-Andres, E. Roze, MJ. Molnar, NI. Wolf, A. Darling, G. Vasco, E. Bertini, E. Indelicato, D. Neubauer, TB. Haack, JC. Sagi, FR. Danti, D. Sival, G. Zanni,...
Language English Country Italy
Document type Journal Article
Grant support
ERN-RND Framework Partnership Agreement 2022-23
European Union
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
Family Health Database (ProQuest)
from 2000-01-01 to 1 year ago
Psychology Database (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Child MeSH
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Nervous System Diseases * diagnosis therapy MeSH
- Delivery of Health Care * MeSH
- Surveys and Questionnaires MeSH
- Rare Diseases diagnosis therapy MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Adolescent MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
BACKGROUND: Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions. AIM: To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND). METHODS: Members of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network. RESULTS: Twenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice. CONCLUSIONS: This survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.
Center for Rare Movement Disorders Department of Neurology Innsbruck Austria
Department of Pediatric Neurosciences Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy
Institute of Genomic Medicine and Rare Disorders Semmelweis University Budapest Hungary
Institute of Medical Genetics and Applied Genomics University of Tübingen Tübingen Germany
Osservatorio Malattie Rare Rarelab S R L Rome Italy
Research Unit of Neurorehabilitation IRCCS Bambino Gesù Children's Research Hospital Rome Italy
Sorbonne University INSERM CNRS Paris Brain Institute APHP Salpêtrière Hospital Paris France
Tartu University Hospital Children's Clinic Department of Pediatrics and Neurology Tartu Estonia
UMCL Children's Hospital Ljubljana and University of Ljubljana Ljubljana Slovenia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24006998
- 003
- CZ-PrNML
- 005
- 20240423155635.0
- 007
- ta
- 008
- 240412s2024 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10072-023-07101-3 $2 doi
- 035 __
- $a (PubMed)37853291
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Nanetti, Lorenzo $u Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy
- 245 10
- $a Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND) / $c L. Nanetti, M. Kearney, S. Boesch, L. Stovickova, JD. Ortigoza-Escobar, A. Macaya, D. Gomez-Andres, E. Roze, MJ. Molnar, NI. Wolf, A. Darling, G. Vasco, E. Bertini, E. Indelicato, D. Neubauer, TB. Haack, JC. Sagi, FR. Danti, D. Sival, G. Zanni, A. Kolk, O. Boespflug-Tanguy, L. Schols, B. van de Warrenburg, M. Vidailhet, MA. Willemsen, AI. Buizer, E. Orzes, S. Ripp, C. Reinhard, I. Moroni, C. Mariotti, ERN-RND Working Group for Management of Transition
- 520 9_
- $a BACKGROUND: Transition from child-centered to adult-centered healthcare is a gradual process that addresses the medical, psychological, and educational needs of young people in the management of their autonomy in making decisions about their health and their future clinical assistance. This transfer is challenging across all chronic diseases but can be particularly arduous in rare neurological conditions. AIM: To describe the current practice on the transition process for young patients in centers participating in the European Reference Network for Rare Neurological Diseases (ERN-RND). METHODS: Members of the ERN-RND working group developed a questionnaire considering child-to-adult transition issues and procedures in current clinical practice. The questionnaire included 20 questions and was sent to members of the health care providers (HCPs) participating in the network. RESULTS: Twenty ERN-RND members (75% adult neurologists; 25% pediatricians; 5% nurses or study coordinators) responded to the survey, representing 10 European countries. Transition usually occurs between 16 and 18 years of age, but 55% of pediatric HCPs continue to care for their patients until they reach 40 years of age or older. In 5/20 ERN-RND centers, a standardized procedure managing transition is currently adopted, whereas in the remaining centers, the transition from youth to adult service is usually assisted by pediatricians as part of their clinical practice. CONCLUSIONS: This survey demonstrated significant variations in clinical practice between different centers within the ERN-RND network. It provided valuable data on existing transition programs and highlighted key challenges in managing transitions for patients with rare neurological disorders.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 12
- $a poskytování zdravotní péče $7 D003695
- 650 12
- $a nemoci nervového systému $x diagnóza $x terapie $7 D009422
- 650 _2
- $a vzácné nemoci $x diagnóza $x terapie $7 D035583
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kearney, Mary $u Patient Advocate at the European Reference Network Representing Individuals With Ataxia, and Neurology Research Fellow at the National Ataxia Centre, Tallaght University, Dublin, Ireland
- 700 1_
- $a Boesch, Sylvia $u Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria
- 700 1_
- $a Stovickova, Lucie $u Centre of Hereditary Ataxias, Department of Pediatric Neurology, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Ortigoza-Escobar, Juan Darío $u Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
- 700 1_
- $a Macaya, Alfons $u Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Gomez-Andres, David $u Pediatric Neurology, Vall d'Hebron Institut de Recerca, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, and Universitat Autònoma de Barcelona, Bellaterra, Spain
- 700 1_
- $a Roze, Emmanuel $u Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France
- 700 1_
- $a Molnar, Maria-Judit $u Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Wolf, Nicole I $u Amsterdam Leukodystrophy Center, Department of Child Neurology, Emma's Children's Hospital, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Cellular & Molecular Mechanisms, Amsterdam, The Netherlands
- 700 1_
- $a Darling, Alejandra $u Pediatric Neurology Department, Institut de Recerca Hospital Sant Joan de Déu Barcelona, Barcelona, Spain
- 700 1_
- $a Vasco, Gessica $u Research Unit of Neurorehabilitation, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
- 700 1_
- $a Bertini, Enrico $u Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
- 700 1_
- $a Indelicato, Elisabetta $u Center for Rare Movement Disorders, Department of Neurology, Innsbruck, Austria
- 700 1_
- $a Neubauer, David $u UMCL, Children's Hospital Ljubljana and University of Ljubljana, Ljubljana, Slovenia
- 700 1_
- $a Haack, Tobias B $u Institute of Medical Genetics and Applied Genomics University of Tübingen, Tübingen, Germany
- 700 1_
- $a Sagi, Judit C $u Institute of Genomic Medicine and Rare Disorders, Semmelweis University, Budapest, Hungary $u Department of Paediatrics, Semmelweis University, Dept. of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Danti, Federica R $u Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 700 1_
- $a Sival, Deborah $u Department of Paediatric Neurology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- 700 1_
- $a Zanni, Ginevra $u Unit of Neuromuscular and Neurodegenerative Disease, IRCCS Bambino Gesù Children's Research Hospital, Rome, Italy
- 700 1_
- $a Kolk, Anneli $u Tartu University Hospital Children's Clinic, Department of Pediatrics and Neurology, Tartu, Estonia
- 700 1_
- $a Boespflug-Tanguy, Odile $u APHP, Université Paris Cité, INSERM UMR1141, Hôpital Robert Debré, Service de Neuropédiatrie, Centre de Reference LEUKOFRANCE, Paris, France
- 700 1_
- $a Schols, Ludger $u Department of Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, and German Center for Neurodegenerative Diseases, Tübingen, Germany
- 700 1_
- $a van de Warrenburg, Bart $u Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands
- 700 1_
- $a Vidailhet, Marie $u Sorbonne University, INSERM, CNRS, Paris Brain Institute, APHP Salpêtrière Hospital, Paris, France
- 700 1_
- $a Willemsen, Michèl A $u Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands
- 700 1_
- $a Buizer, Annemieke I $u Department of Rehabilitation Medicine, Emma Children's Hospital, Amsterdam, Vrije Universiteit, Amsterdam, Amsterdam Movement Science, Rehabilitation and Development, Amsterdam, The Netherlands
- 700 1_
- $a Orzes, Enrico $u Osservatorio Malattie Rare - Rarelab S.R.L., Rome, Italy
- 700 1_
- $a Ripp, Sophie $u Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
- 700 1_
- $a Reinhard, Carola $u Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Tübingen, Germany
- 700 1_
- $a Moroni, Isabella $u Department of Pediatric Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
- 700 1_
- $a Mariotti, Caterina $u Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy. caterina.mariotti@istituto-besta.it $1 https://orcid.org/0000000324053564
- 710 2_
- $a ERN-RND Working Group for Management of Transition
- 773 0_
- $w MED00005781 $t Neurological sciences $x 1590-3478 $g Roč. 45, č. 3 (2024), s. 1007-1016
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37853291 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155632 $b ABA008
- 999 __
- $a ok $b bmc $g 2081161 $s 1216765
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 45 $c 3 $d 1007-1016 $e 20231019 $i 1590-3478 $m Neurological sciences $n Neurol Sci $x MED00005781
- GRA __
- $a ERN-RND Framework Partnership Agreement 2022-23 $p European Union
- LZP __
- $a Pubmed-20240412